FDMT - 4D Molecular Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FDMT is currently covered by 9 analysts with an average price target of $29.06. This is a potential upside of $24.53 (541.5%) from yesterday's end of day stock price of $4.53.

4D Molecular Therapeutics 's activity chart (see below) currently has 17 price targets and 53 ratings on display. The stock rating distribution of FDMT is 90.24% BUY, 4.88% HOLD and 4.88% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.46% with an average time for these price targets to be met of 98.33 days.

Highest price target for FDMT is $40, Lowest price target is $6, average price target is $29.06.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 11-Feb-2025. First documented stock forecast 05-Jan-2021.

Currently out of the existing stock ratings of FDMT, 37 are a BUY (90.24%), 2 are a HOLD (4.88%), 2 are a SELL (4.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$39

20 days ago
(11-Feb-2025)

3/5 (60%)

$25.5 (188.89%)

201

Buy

21 days ago
(10-Feb-2025)

0/14 (0%)

$27.98 (348.88%)

Buy

$36

1 months 18 days ago
(13-Jan-2025)

7/8 (87.5%)

$22.5 (166.67%)

285

Buy

$81

1 months 18 days ago
(13-Jan-2025)

0/2 (0%)

$52.76 (186.83%)

Sell

$6

$1.47 (32.45%)

$8

1 months 18 days ago
(13-Jan-2025)

1/2 (50%)

$1.24 (26.05%)

23

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FDMT (4D Molecular Therapeutics ) average time for price targets to be met?

On average it took 98.33 days on average for the stock forecasts to be realized with a an average price target met ratio 40.46

Which analyst has the current highest performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

GEULAH LIVSHITS

Which analyst has the current lower performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

TAZEEN AHMAD

Which analyst has the most public recommendations on FDMT (4D Molecular Therapeutics )?

Geulah Livshits works at CHARDAN CAPITAL and has 9 price targets and 12 ratings on FDMT

Which analyst is the currently most bullish on FDMT (4D Molecular Therapeutics )?

Kostas Biliouris with highest potential upside - $35.47

Which analyst is the currently most reserved on FDMT (4D Molecular Therapeutics )?

Mani Foroohar with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?